BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 4137236)

  • 1. Testosterone metabolism in benign prostatic hypertrophy. Suppression by diethylstilbestrol and gestonorone capronate.
    Orestano F; Klose K; Rubin A; Knapstein P; Altwein JE
    Invest Urol; 1974 Sep; 12(2):151-6. PubMed ID: 4137236
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of estradiol, diethylstilbestrol, progesterone, and gestonorone capronate (depostat) on the 5 alpha-reductase kinetics in benign prostatic hypertrophy (BPH) (author's transl)].
    Altwein JE; Rubin A; Klose K; Knapstein P; Orestano F
    Urologe A; 1974 Jan; 13(1):41-6. PubMed ID: 4132876
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of gestonoron-capronate (GC) upon uptake and metabolism of H3-testosteron in benign prostatic hypertrophy (BPH): in vivo-experiments (author's transl)].
    Orestano F; Bandhauer K; Altwein JE
    Urologe A; 1974 Nov; 13(6):289-92. PubMed ID: 4141158
    [No Abstract]   [Full Text] [Related]  

  • 4. Testosterone turnover in cancer of the prostate: suppression by gestagens in vitro.
    Altwein JE; Orestano F; Hohenfellner R
    Invest Urol; 1974 Sep; 12(2):157-61. PubMed ID: 4854628
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recent results of prostatic adenoma research].
    Kaufmann J
    Z Urol Nephrol; 1975 Nov; 68(11):. PubMed ID: 58501
    [No Abstract]   [Full Text] [Related]  

  • 6. Testosterone metabolism in benign prostatic hypertrophy: in vivo studies of gestonorone caproate and cyproterone acetate.
    Orestano F; Altwein JE
    Br J Urol; 1976 Dec; 48(6):485-91. PubMed ID: 64267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary report on the effect of gestonorone capronate on human prostate LDH-isoenzymes.
    Govaerts J; van Sande M; Van Camp K
    Acta Urol Belg; 1978; 46(4):389-92. PubMed ID: 83788
    [No Abstract]   [Full Text] [Related]  

  • 8. Mode of action of progesterone, gestonorone capronate (Depostat) and cyproterone acetate (Androcur) on the metabolism of testosterone in human prostatic adenoma: in vitro and in vivo investigations.
    Orestano F; Altwein JE; Knapstein P; Bandhauer K
    J Steroid Biochem; 1975 Jun; 6(6):845-51. PubMed ID: 1177428
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of stilbestrol on the metabolism of testosterone by benign prostatic hyperplasia in organ culture.
    McMahon MJ; Thomas GH
    Br J Surg; 1971 Nov; 58(11):869. PubMed ID: 4108125
    [No Abstract]   [Full Text] [Related]  

  • 10. Steroids of adrenal origin metabolized by human prostatic tissue both in vivo and in vitro.
    Harper ME; Pike A; Peeling WB; Griffiths K
    J Endocrinol; 1974 Jan; 60(1):117-25. PubMed ID: 4130214
    [No Abstract]   [Full Text] [Related]  

  • 11. Androgen metabolism in patients with benign prostatic hypertrophy.
    Voigt KD; Horst HJ; Krieg M
    Vitam Horm; 1975; 33():417-38. PubMed ID: 59462
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of the progestogen gestonorone caproate on testosterone turnover in renal cell carcinoma. An in vitro study.
    Marberger M; Altwein JE; Orestano F
    Invest Urol; 1976 Jan; 13(4):302-6. PubMed ID: 1245393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen assimilation by normal and hyperplastic dog prostate glands.
    Mawhinney MG; Schwartz FL; Thomas JA; Lloyd JW
    Invest Urol; 1974 Jul; 12(1):17-22. PubMed ID: 4135034
    [No Abstract]   [Full Text] [Related]  

  • 14. Conversion of 3H-testosterone to dihydrotestosterone in human hypertrophic prostatic tissue.
    Baranowska B; Zgliczyński S
    Nuklearmedizin; 1979; 18(6):297-9. PubMed ID: 94161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone 5 alpha-reductase and the accumulation of dihydrotestosterone in benign prostatic hyperplasia.
    Cowan RA; Cook B; Cowan SK; Grant JK; Sirett DA; Wallace AM
    J Steroid Biochem; 1979 Jul; 11(1B):609-13. PubMed ID: 90753
    [No Abstract]   [Full Text] [Related]  

  • 16. Testosterone metabolism in human prostatic tissue and blood in patients with benign prostatic hypertrophy (BPH).
    Becker H; Buric L; Petersen C; Voigt KD
    Acta Endocrinol Suppl (Copenh); 1971; 152():28. PubMed ID: 4101325
    [No Abstract]   [Full Text] [Related]  

  • 17. Androgen binding and metabolism in the human prostate.
    Attramadal A; Tveter KJ; Weddington SC; Djöseland O; Naess O; Hansson V; Torgersen O
    Vitam Horm; 1975; 33():247-64. PubMed ID: 59460
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo uptake and metabolism of 3H-testosterone and 3H-5 -dihydrotestosterone by human benign prostatic hypertrophy.
    Becker H; Kaufmann J; Klosterhalfen H; Voigt KD
    Acta Endocrinol (Copenh); 1972 Nov; 71(3):589-99. PubMed ID: 4117573
    [No Abstract]   [Full Text] [Related]  

  • 19. Steroids and the prostate.
    Peeling WB; Griffiths K
    Proc R Soc Med; 1972 Feb; 65(2):127-8. PubMed ID: 5085013
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of benign prostatic hypertrophy with gestonorone caproate].
    Baranowska B; Kuzaka B
    Pol Tyg Lek; 1984 Jul 16-23; 39(29-30):999-1003. PubMed ID: 6209689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.